Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome
- 11 April 2007
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 197 (1) , 139-146
- https://doi.org/10.1016/j.atherosclerosis.2007.03.004
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemiaPharmacology & Therapeutics, 2004
- Mechanism of Action of a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor on Apolipoprotein B-100 Kinetics in Visceral ObesityJournal of Clinical Endocrinology & Metabolism, 2002
- Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?American Journal of Physiology-Endocrinology and Metabolism, 2001
- The Insulin Resistance Syndrome: Impact on Lipoprotein Metabolism and AtherothrombosisEuropean Journal of Cardiovascular Risk, 2000
- Insulin resistance and cardiovascular diseaseJournal of Clinical Investigation, 2000
- Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesityInternational Journal of Obesity, 1998
- Statin trials and goals of cholesterol-lowering therapy.Circulation, 1998
- The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in menDiabetes Care, 1996
- Modulation of Lipoprotein B Binding to the LDL Receptor by Exogenous Lipids and Apolipoproteins CI, CII, CIII, and EArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.Journal of Clinical Investigation, 1986